These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 31706700

  • 1. Impact of iron chelators on growth and expression of iron-related genes of Cryptococcus species.
    Chayakulkeeree M, Tangkoskul T, Waywa D, Tiengrim S, Pati N, Thamlikitkul V.
    J Mycol Med; 2020 Apr; 30(1):100905. PubMed ID: 31706700
    [Abstract] [Full Text] [Related]

  • 2. Synergy and antagonism between iron chelators and antifungal drugs in Cryptococcus.
    Lai YW, Campbell LT, Wilkins MR, Pang CN, Chen S, Carter DA.
    Int J Antimicrob Agents; 2016 Oct; 48(4):388-94. PubMed ID: 27474467
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of antifungal combination against Cryptococcus spp.
    Reichert-Lima F, Busso-Lopes AF, Lyra L, Peron IH, Taguchi H, Mikami Y, Kamei K, Moretti ML, Schreiber AZ.
    Mycoses; 2016 Sep; 59(9):585-93. PubMed ID: 27135278
    [Abstract] [Full Text] [Related]

  • 4. In vitro interaction of antifungal and antibacterial drugs against Cryptococcus neoformans var. grubii before and after capsular induction.
    Rossato L, Loreto ÉS, Venturini TP, Azevedo MI, Weiblen C, Botton SA, Santurio JM, Alves SH.
    Med Mycol; 2015 Nov; 53(8):885-9. PubMed ID: 26333356
    [Abstract] [Full Text] [Related]

  • 5. Synergistic effect of pyrvinium pamoate and posaconazole against Cryptococcus neoformans in vitro and in vivo.
    Li Y, Li S, Chen M, Xiao J, Fang H.
    Front Cell Infect Microbiol; 2022 Nov; 12():1074903. PubMed ID: 36569209
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synergistic effect of the verapamil and amphotericin B against Cryptococcus neoformans.
    Pereira TC, do Carmo PHF, de Menezes RT, de Oliveira HC, de Oliveira LD, Junqueira JC, Scorzoni L.
    Folia Microbiol (Praha); 2023 Dec; 68(6):999-1004. PubMed ID: 37950840
    [Abstract] [Full Text] [Related]

  • 11. Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
    Barchiesi F, Schimizzi AM, Caselli F, Novelli A, Fallani S, Giannini D, Arzeni D, Di Cesare S, Di Francesco LF, Fortuna M, Giacometti A, Carle F, Mazzei T, Scalise G.
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2435-41. PubMed ID: 10952592
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A potential of propolis on major virulence factors of Cryptococcus neoformans.
    Thammasit P, Iadnut A, Mamoon K, Khacha-Ananda S, Chupradit K, Tayapiwatana C, Kasinrerk W, Tragoolpua Y, Tragoolpua K.
    Microb Pathog; 2018 Oct; 123():296-303. PubMed ID: 30041002
    [Abstract] [Full Text] [Related]

  • 14. Antifungal and antibiofilm effect of duloxetine hydrochloride against Cryptococcus neoformans and Cryptococcus gattii.
    Rehem AR, da Gama Viveiro LR, De Souza Santos EL, do Carmo PHF, da Silva NS, Junqueira JC, Scorzoni L.
    Folia Microbiol (Praha); 2024 Dec; 69(6):1247-1254. PubMed ID: 38652436
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Brilacidin, a novel antifungal agent against Cryptococcus neoformans.
    Diehl C, Pinzan CF, de Castro PA, Delbaje E, García Carnero LC, Sánchez-León E, Bhalla K, Kronstad JW, Kim D-g, Doering TL, Alkhazraji S, Mishra NN, Ibrahim AS, Yoshimura M, Vega Isuhuaylas LA, Pham LTK, Yashiroda Y, Boone C, Dos Reis TF, Goldman GH.
    mBio; 2024 Jul 17; 15(7):e0103124. PubMed ID: 38916308
    [Abstract] [Full Text] [Related]

  • 17. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
    Hagen F, Hare Jensen R, Meis JF, Arendrup MC.
    Mycoses; 2016 Sep 17; 59(9):576-84. PubMed ID: 27061834
    [Abstract] [Full Text] [Related]

  • 18. Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts.
    Spadari CC, Vila T, Rozental S, Ishida K.
    Antimicrob Agents Chemother; 2018 Aug 17; 62(8):. PubMed ID: 29844051
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interactions between antifungals and everolimus against Cryptococcus neoformans.
    Liang P, Song J, Liu Q.
    Front Cell Infect Microbiol; 2023 Aug 17; 13():1131641. PubMed ID: 37026056
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.